Literature DB >> 7513550

Chromosome abnormalities in pancreatic adenocarcinoma.

C A Griffin1, R H Hruban, P P Long, L A Morsberger, F Douna-Issa, C J Yeo.   

Abstract

Adenocarcinoma of the pancreas is the fifth most common cause of cancer deaths in the United States, yet few cytogenetic studies of this tumor have been reported. We analyzed 26 primary tumors to identify which chromosome abnormalities occur most frequently in this neoplasm. One carcinoma was well differentiated and mucin producing, 18 were moderately well differentiated, and seven were poorly differentiated. Only normal karyotypes were obtained from nine carcinomas. The remaining 17 carcinomas frequently had normal metaphase cells in addition to simple to highly complex karyotypes. The modal chromosome number in 20 carcinomas was diploid or near-diploid; four carcinomas had both a major near-diploid and near-triploid or near-tetraploid component, and two were near-tetraploid. Numerical abnormalities included loss of whole copies of chromosomes 6, 17, and 18, and gains of chromosome 20. Structural abnormalities were frequent, with 1p, 2p, 3p, 4q, 6q, 7q, 11q, and 17p recurrently involved. Results of this study were combined with karyotypes of 19 other primary adenocarcinomas of the pancreas reported in the literature. The combined data involving 117 breakpoints suggest that careful analysis of chromosome 20, proximal 1q, 6q, proximal 8p, and proximal 17p could be productive in defining genes involved in adenocarcinoma of the pancreas.

Entities:  

Mesh:

Year:  1994        PMID: 7513550     DOI: 10.1002/gcc.2870090204

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  8 in total

1.  Intraductal papillary mucinous neoplasms of the pancreas: pathology and molecular genetics.

Authors:  N Volkan Adsay
Journal:  J Gastrointest Surg       Date:  2002 Sep-Oct       Impact factor: 3.452

2.  Transflip mutations produce deletions in pancreatic cancer.

Authors:  Alexis L Norris; Hirohiko Kamiyama; Alvin Makohon-Moore; Aparna Pallavajjala; Laura A Morsberger; Kurt Lee; Denise Batista; Christine A Iacobuzio-Donahue; Ming-Tseh Lin; Alison P Klein; Ralph H Hruban; Sarah J Wheelan; James R Eshleman
Journal:  Genes Chromosomes Cancer       Date:  2015-05-29       Impact factor: 5.006

3.  Specific chromosomal aberrations and amplification of the AIB1 nuclear receptor coactivator gene in pancreatic carcinomas.

Authors:  B M Ghadimi; E Schröck; R L Walker; D Wangsa; A Jauho; P S Meltzer; T Ried
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

4.  High-resolution characterization of the pancreatic adenocarcinoma genome.

Authors:  Andrew J Aguirre; Cameron Brennan; Gerald Bailey; Raktim Sinha; Bin Feng; Christopher Leo; Yunyu Zhang; Jean Zhang; Joseph D Gans; Nabeel Bardeesy; Craig Cauwels; Carlos Cordon-Cardo; Mark S Redston; Ronald A DePinho; Lynda Chin
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-15       Impact factor: 11.205

5.  Human pancreatic cancer progression: an anarchy among CCN-siblings.

Authors:  Sushanta K Banerjee; Gargi Maity; Inamul Haque; Arnab Ghosh; Sandipto Sarkar; Vijayalaxmi Gupta; Donald R Campbell; Daniel Von Hoff; Snigdha Banerjee
Journal:  J Cell Commun Signal       Date:  2016-08-19       Impact factor: 5.782

6.  Palladin mutation causes familial pancreatic cancer and suggests a new cancer mechanism.

Authors:  Kay L Pogue-Geile; Ru Chen; Mary P Bronner; Tatjana Crnogorac-Jurcevic; Kara White Moyes; Sally Dowen; Carol A Otey; David A Crispin; Ryan D George; David C Whitcomb; Teresa A Brentnall
Journal:  PLoS Med       Date:  2006-12       Impact factor: 11.069

7.  Chromosomal imbalances in primary and metastatic pancreatic carcinoma as detected by interphase cytogenetics: basic findings and clinical aspects.

Authors:  N Zojer; M Fiegl; L Müllauer; A Chott; S Roka; J Ackermann; M Raderer; H Kaufmann; A Reiner; H Huber; J Drach
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

8.  Identification of disease-associated pathways in pancreatic cancer by integrating genome-wide association study and gene expression data.

Authors:  Jin Long; Zhe Liu; Xingda Wu; Yuanhong Xu; Chunlin Ge
Journal:  Oncol Lett       Date:  2016-05-26       Impact factor: 2.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.